| [1] |
HE Ying, LI Mengjiao, CEN Yali, DOU Baitao, SHU Rou, LI Yanling, YAO Hao, FAN Fangyi.
CD19 CAR T-cell therapy: a case of refractory primary central nervous system diffuse large B-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 571-576.
|
| [2] |
LIU Jingqian, ZHANG Yajing.
Strategies for prevention,control and management of CAR-T cell therapy related adverse reactions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 540-548.
|
| [3] |
BIAN Weigang, CHEN Ping, ZHOU Xiaoning, CHEN Haiting, SONG Shu.
LncRNA SNHG1 targets miR-101-3p to regulate oxaliplatin resistance in gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(3): 242-247.
|
| [4] |
HAN Zhongcheng, MA Lili, CUI Zhiwen, FENG Yanyan, WANG Fang.
Efficacy of first-line SOX chemotherapy plus Apatinib for advanced gastric cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(1): 62-67.
|
| [5] |
Guo Liang,Lin Fei,Yu Meigang,Dai Huijun,Du Xueke,Pan Linghui.
Effect of preoperative chemotherapy with oxaliplatin on postoperative cognitive dysfunction in elderly patients with gastrointestinal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 299-304.
|
| [6] |
Yang Liuting,Jiang Penglei,Zu Dandan,Li Meining,Zhang Dong,Chang Bingmei.
Effect of NK4 gene expression combined with oxaliplatin on apoptosis and invasion by human colorectal cancer HCT116 cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(6): 456-461.
|
| [7] |
Yin Haiqing,Gao Shoubao,Shan Huiguo,Duan Xueyu.
Efficacy and safety of capecitabine maintenance therapy for patients with advanced gastric cancer after first-line XELOX chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(5): 291-294.
|
| [8] |
He Ying,Wei Minglang,Wang Daiyou.
The clinical comparative observation of preoperative induction chemotherapy with TOF or TPF regimen for advanced oral squamous cell carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(3): 161-164.
|
| [9] |
Shao Peng,Yu Xinlin,Hu Wei,Li Yuechun,Wang Junchen,Wen Zhizhen.
Clinical observations of S-1 combined with transarterial infusion with oxaliplatin and em-bolism to treat advanced gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(2): 96-99.
|
| [10] |
MO Han-wen,LI Li-ping,Huang Li-hua,et al..
The effect of docetaxel and fluorouracil combined with oxaliplatin or cisplatin on advanced nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2010, 2(03): 196-198.
|
| [11] |
KANG Ma-fei,LUO Mei-qing,LI Bi-hui,et al..
Efficacy of Oxaliplatin combined with Vinorelbine or Gemcitabine on Cisplatin-and Taxane-resistant or refractory advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2009, 1(04): 324-326.
|
| [12] |
LIN Yan,XU You-qi,DING Rong..
The interference effect of Chinese herbal compound on Oxaliplatin-induced neurotoxicity
[J]. Chinese Journal of Oncology Prevention and Treatment, 2009, 1(04): 333-334.
|
| [13] |
KANG Ma-fei,LUO Mei-qing,LI Bi-hui,et al..
Efficacy of Oxaliplatin combined with Vinorelbine or Gemcitabine on Cisplatin-and Taxane-resistant or refractory advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2009, 1(04): 324-326.
|
